Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea.
Osong public health and research perspectives(2022)
摘要
The overall results are consistent with previous findings; the great majority of adverse events were non-serious, and serious adverse events were rare among adolescents aged 12 to 17 years following Pfizer-BioNTech COVID-19 vaccination.
更多查看译文
关键词
Adolescent,COVID-19,Safety,Vaccination,Vaccines
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要